Home » Topics » BioWorld Science

BioWorld Science
RSS

ATH-1017 positively modulates HGF/MET axis and shows procognitive effects

March 4, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

Inhibiting DsbA inactivates resistance enzymes, sensitizing AMR bacteria to existing antibiotics

March 4, 2022

Biomind reports in vivo findings with DMT combination drug BMND-07

March 4, 2022

TRIM14 is a potential therapeutic target for treating inflammation-driven diseases

March 4, 2022

Engineered retinal cells stare daggers at peritoneal tumors

March 4, 2022

Phenanthroline derivative with antitumor activity in liver cancer models

March 4, 2022

Targeting alpha2-Na+/K+ ATPase improves tau pathology in vivo

March 4, 2022

Cornell University patents PROTACs targeting BET domain proteins

March 4, 2022

New mucolipin-1 agonists divulged by Casma Therapeutics

March 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...